You are here

Research News

Risk May Remain for 6 Months After Treatment
May Lead to Personalized Treatment for Schizophrenia, Other Illnesses
New Technique Could Benefit Patients With End-stage Lung Disease
Vaccine Can Prevent Painful Rash That Could Cause Vision Loss
Axonal Fusion Process Could Someday Translate to Humans
Neurofilament Light Protein Correlated With Accumulated Brain Damage
Hope for Sufferers With Post-Treatment Lyme Disease Syndrome
Antibiotics, Statins, and Glucocorticoids All Show Promise
Potential For Use Against E. Coli, TB, Resistant Bacteria
Drug Improved or Stabilized Symptoms, Shrank Brain Lesions
Drug Candidate May Prevent Virus From Fusing With Epithelial Cells, B Cells
Optogenetics Provides Insights Into Basis of Fear, Addiction
Genes Are Expressed from Early Pregnancy Through Adulthood
Combination of Two Drugs Could Reduce Tumor Growth
PARG Inhibitor Exploits Weakness, Kills Cells
Synergistic Effects Seen When Combined With Cisplatin in Mice
Small-Molecule Drug Blocks Oxidative Stress Signals
Bone-Marrow Transplant Succeeded, But Still Considered Risky
Possible Danger With Stopping and Starting Anti-Rejection Drugs
UCLA Scientists Develop Rapid Screening Method for Hundreds of Drugs
Researchers Seek Ways to Prevent Diabetes Onset in High-Risk Patients
Peak Immune Responses Occur as Early as Seven Days After Treatment
Scan Could Improve Understanding of Dopamine Function in Schizophrenia
Test Determines Severity of Pain, Helps Physicians Select Best Options
Diabetes and Cancer Patients Could Soon Avoid Injections
Early Cancer Development May Begin in Just 30 Minutes